###begin article-title 0
Genetic Analysis of the Role of Protein Kinase Ctheta in Platelet Function and Thrombus Formation
###end article-title 0
###begin p 1
Conceived and designed the experiments: KJH MTH KG JMC JH AWP. Performed the experiments: KJH MTH KG JMC JH. Analyzed the data: KJH MTH KG JMC JH AWP. Wrote the paper: KJH MTH JH AWP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 104 107 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 155 158 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 515 518 491 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 522 523 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
PKCtheta is a novel protein kinase C isozyme, predominately expressed in T cells and platelets. PKCtheta-/- T cells exhibit reduced activation and PKCtheta-/- mice are resistant to autoimmune disease, making PKCtheta an attractive therapeutic target for immune modulation. Collagen is a major agonist for platelets, operating through an immunoreceptor-like signalling pathway from its receptor GPVI. Although it has recently been shown that PKCtheta positively regulates outside-in signalling through integrin alphaIIbbeta3 in platelets, the role of PKCtheta in GPVI-dependent signalling and functional activation of platelets has not been assessed.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 99 102 95 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 106 107 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 278 281 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 493 496 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 729 732 694 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 736 737 698 699 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 921 923 883 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
In the present study we assessed static adhesion, cell spreading, granule secretion, integrin alphaIIbbeta3 activation and platelet aggregation in washed mouse platelets lacking PKCtheta. Thrombus formation on a collagen-coated surface was assessed in vitro under flow. PKCtheta-/- platelets exhibited reduced static adhesion and filopodia generation on fibrinogen, suggesting that PKCtheta positively regulates outside-in signalling, in agreement with a previous report. In contrast, PKCtheta-/- platelets also exhibited markedly enhanced GPVI-dependent alpha-granule secretion, although dense granule secretion was unaffected, suggesting that PKCtheta differentially regulates these two granules. Inside-out regulation of alphaIIbbeta3 activation was also enhanced downstream of GPVI stimulation. Although this did not result in increased aggregation, importantly thrombus formation on collagen under high shear (1000 s-1) was enhanced.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 160 163 148 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 167 168 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
These data suggest that PKCtheta is an important negative regulator of thrombus formation on collagen, potentially mediated by alpha-granule secretion and alphaIIbbeta3 activation. PKCtheta therefore may act to restrict thrombus growth, a finding that has important implications for the development and safe clinical use of PKCtheta inhibitors.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 237 240 237 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Harper1">[1]</xref>
###xml 399 402 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Strehl1">[2]</xref>
###xml 568 571 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Crosby1">[3]</xref>
###xml 573 576 569 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Crosby2">[4]</xref>
###xml 826 829 822 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Harper1">[1]</xref>
The protein kinase C (PKC) family critically regulates platelet activation. Many platelet functional responses, including secretion and aggregation are reduced or abolished by broad-spectrum PKC inhibitors and enhanced by PKC activators [1], suggesting a positive role for the PKC family in general in platelet activation. However, calcium responses are clearly negatively regulated by PKC isoforms [2], and we have shown by pharmacological and genetic approaches that PKCdelta is a negative regulator of platelet aggregation by modulating actin dynamics through VASP [3], [4]. Individual PKC isoforms therefore play distinct roles, both positive and negative, during platelet activation, and the effect of broad-spectrum PKC inhibition or activation reflects a balance of effects on positive and negative regulatory pathways [1].
###end p 9
###begin p 10
###xml 144 147 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Crosby1">[3]</xref>
###xml 148 151 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Wang1">[9]</xref>
###xml 650 654 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Yoshioka1">[10]</xref>
###xml 656 660 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Tabuchi1">[11]</xref>
###xml 700 703 668 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 707 708 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 756 760 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Buensuceso1">[12]</xref>
###xml 887 891 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Pula1">[13]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Human platelets express predominantly four PKC isoforms: alpha, beta, delta and theta. In addition to these, mouse platelets express PKCepsilon [3]-[9]. The specific importance of each isoform is hard to assess by pharmacological approaches owing to the lack of isoform specificity of these agents. The availability of biochemical and genetic tools has allowed the functions of specific isoforms to be addressed. Using such approaches, we and others have recently demonstrated highly specific roles for individual PKC isoforms in regulating platelet function: PKCalpha is critically required for granule secretion and secretion-dependent aggregation [10], [11]; PKCbeta is recruited to integrin alphaIIbbeta3 and positively regulates outside-in signalling [12]; PKCdelta, in contrast, negatively regulates filopodia formation, and lack of PKCdelta leads to enhanced platelet aggregation [13].
###end p 10
###begin p 11
###xml 43 45 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 135 139 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Baier1">[14]</xref>
###xml 141 145 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Chang1">[15]</xref>
###xml 155 158 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 347 351 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Pfeifhofer1">[16]</xref>
###xml 353 357 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Sun1">[17]</xref>
###xml 438 442 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Anderson1">[18]</xref>
###xml 443 447 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Tan1">[20]</xref>
###xml 507 511 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Kim1">[21]</xref>
###xml 584 588 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Cywin1">[22]</xref>
###xml 590 594 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Mosyak1">[23]</xref>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
PKCtheta is a novel (i.e. DAG-sensitive, Ca2+-insensitive) PKC isoform, predominantly expressed in T-cells, muscle cells and platelets [14], [15]. PKCtheta-/- mice exhibit reduced T cell activation, proliferation and IL-2 production downstream of T-cell receptor stimulation, owing to markedly reduced activation of multiple transcription factors [16], [17] and, as a result, these mice are resistant to some models of autoimmune disease [18]-[20]. PKCtheta may also regulate fat-induced insulin resistance [21]. Selective PKCtheta inhibitors are therefore of great clinical interest [22], [23], although none of those currently in development have yet become commercially available.
###end p 11
###begin p 12
###xml 118 121 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Crosby2">[4]</xref>
###xml 561 565 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Soriani1">[24]</xref>
###xml 234 239 <span type="species:ncbi:9606">human</span>
We have previously shown that PKCtheta is physically associated with, and phosphorylated by, the tyrosine kinase, Btk [4]. However, lack of available PKCtheta-selective inhibitors has curtailed research on the role of this isoform in human platelets. Shattil and co-workers have reported PKCtheta-deficient platelets spread poorly on fibrinogen, suggesting that PKCtheta positively regulates outside-in signalling. In addition, they demonstrated that PKCtheta does not regulate platelet activation in response to a Gq/Gi coupled agonists PAR4 agonist or to ADP [24]. However, this study did not examine the role of PKCtheta in collagen-induced platelet activation.
###end p 12
###begin p 13
###xml 464 467 448 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 471 472 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 611 614 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 673 681 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Given the primary role played by collagen in inducing platelet activation during the very early stages of thrombosis, and the parallels between signalling downstream of the collagen receptor GPVI and that downstream of immunoreceptors, it was now important to determine the role played by PKCtheta in collagen-induced platelet activation and thrombus formation. We report that PKCtheta negatively regulates GPVI-dependent alpha-granule secretion and integrin alphaIIbbeta3 activation and thereby is the only PKC isoform yet described with this function. Furthermore, loss of this negative regulation in PKCtheta-/- platelets leads to enhanced thrombus formation under flow in vitro. These results reveal a novel negative regulatory pathway in platelet activation, and have relevance to the current clinical and pharmaceutical interest in PKCtheta inhibitors.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Materials
###end title 15
###begin p 16
###xml 654 665 <span type="species:ncbi:3704">horseradish</span>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
###xml 718 724 <span type="species:ncbi:9986">rabbit</span>
Unless stated, all reagents were from Sigma Aldrich (Poole, Dorset, U.K.). Cross-linked collagen-related peptide (CRP) was from Professor Richard Farndale (Biochemistry, University of Cambridge, U.K.). Horm collagen was from Axis Shield (Bicton, Cambs., U.K.). Phycoerythrin (PE)-labelled JON/A and fluorescein isothiocyanate (FITC)-labelled Wug.E9 (anti-P-selectin) antibodies were from Emfret Analytics (Eibelstadt, Germany). Anti-PKCalpha, -PKCbeta, -PKCdelta, -PKCepsilon and anti-tubulin antibodies were from BD Transduction Laboratories (Oxford, U.K). Anti-PKCtheta antibody was from Cell Signaling Technology (New England BioLabs, Hitchin, U.K.). horseradish-peroxidase (HRP)-conjugated anti-mouse IgG and anti-rabbit IgG secondary antibodies, and enhanced chemiluminescent (ECL) reagents were from Amersham (Little Chalfont, Bucks., U.K.). Luciferin-luciferase reagent was from Chronolog (LabMedics, Manchester, U.K.).
###end p 16
###begin title 17
Washed platelet preparation
###end title 17
###begin p 18
###xml 8 11 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 61 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Sun1">[17]</xref>
###xml 361 365 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Pula1">[13]</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
PKCtheta-/- C57BL6/J mice have been described previously [17]. Wildtype C57BL6/J mice were used as control. Use of mouse platelets was approved by local research ethics committee at the University of Bristol, U.K. and mice were bred for this purpose under UK Home Office licence (PPL 30/2386) held by AWP. Washed platelets were prepared as previously described [13]. Of note, platelets were treated with indomethacin (10 microM). Platelets were rested for 30 min after centrifugation.
###end p 18
###begin title 19
Electrophoresis and Western blotting
###end title 19
###begin p 20
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 225 231 <span type="species:ncbi:9913">bovine</span>
Washed platelets (2x108/ml) were lysed in Laemmli sample buffer. Proteins were resolved by electrophoresis in 9% SDS-polyacrylamide gels. Samples were then transferred to polyvinylidene difluoride membranes, blocked with 10% bovine serum albumin, and subjected to immunoblotting with specific antibodies to various PKC isoforms, as described in the text. Primary antibody binding was detected by HRP-conjugated secondary antibodies are revealed using ECL reagents.
###end p 20
###begin title 21
Aggregation
###end title 21
###begin p 22
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
Washed platelets (2x108/ml) were stimulated by CRP or collagen in an aggregometer (Chrono-Log, Labmedics, Manchester, U.K.) at 37degreesC, under continuous stirring at 1000 rpm. Aggregation was monitored by optical turbidometry.
###end p 22
###begin title 23
Dense granule secretion
###end title 23
###begin p 24
ATP release from dense granules was monitored using Chrono-Lume luciferin-luciferase reagent according to the manufacturer's instructions.
###end p 24
###begin title 25
###xml 17 20 13 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 24 25 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Analysis of alphaIIbbeta3 activation and alpha-granule secretion by flow cytometry
###end title 25
###begin p 26
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 155 158 151 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 162 163 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Washed platelets (4x107/ml) were aliquoted into tubes containing optimal concentrations of PE-JON/A or FITC-anti-CD62P, which bind to active integrin alphaIIbbeta3 and surface-exposed P-selectin (CD62P), respectively, and CRP at the final concentrations indicated, for 15 min. Analysis of 20,000 events was performed using a Becton Dickinson FACScan. The platelet population as identified by forward and side scatter profile. Data were analysed using WinMDI version 2.8.
###end p 26
###begin title 27
DIC imaging of platelet adhesion and spreading
###end title 27
###begin p 28
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Pula1">[13]</xref>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
Measurement of static platelet adhesion and spreading was performed as previously described [13]. Glass coverslips were coated with fibrinogen, CRP or collagen and mounted in a live-cell chamber. Adhesion and spreading of washed platelets (2x107/ml) was followed by differential interference contrast (DIC) microscopy with a wide-field microscope DM IRB attached to an ORCA ER camera (63x/1.40 NA oil objective) (Leica Microsystems, Milton Keynes, UK). Images were processed with OpenLab 4.03 (Improvision). The surface area of adherent platelets was measured using Volocity software (Improvision), while the number of adherent platelets was counted manually.
###end p 28
###begin title 29
In vitro thrombus formation
###end title 29
###begin p 30
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Kuijpers1">[25]</xref>
###xml 398 400 398 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
Flow-induced thrombus formation was assessed basically as described before [25]. A Leica wide-field microscope DM IRB (63x/1.40 NA oil objective), attached to an ORCA ER camera was used for image capture (Leica Microsystems, Milton Keynes, UK). Heparin/PPACK-anticoagulated mouse blood was flowed over immobilised collagen through a parallel plate perfusion chamber, at a fixed shear rate of 1000 s-1 for 4 minutes. For each experiment, at least 10 random phase-contrast images were captured, which were then averaged. Recorded images were analyzed with ImagePro software.
###end p 30
###begin title 31
Statistics
###end title 31
###begin p 32
###xml 250 254 <span type="species:ncbi:10090">mice</span>
Statistical analyses were performed using GraphPad Prism software, unless stated otherwise, using two-way ANOVA with Bonferroni post-test; p<0.05 was considered significant. Bar charts show mean data+/-SEM (where 'n' denotes the number of individual mice used).
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 8 11 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PKCtheta-/- platelets exhibit normal expression of other PKC isoforms
###end title 34
###begin p 35
###xml 67 70 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 437 440 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 477 483 444 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g001">Fig. 1</xref>
###xml 609 615 572 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g001">Fig. 1</xref>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
In order to be confident that any differences seen between PKCtheta-/- and wild-type (WT) platelets were due to loss of PKCtheta, and not due to altered expression of other PKC isoforms, we assessed the expression of the major PKC isoforms in platelets by western blotting. In addition to PKCtheta, mouse platelets strongly express PKCalpha, -beta, -delta, and -epsilon. No difference in expression of these isoforms was seen in PKCtheta-/- platelets relative to WT platelets (Fig. 1). The blotting membranes were stripped and re-probed for alpha-tubulin, to ensure equal loading of proteins between samples (Fig. 1, lower panels).
###end p 35
###begin title 36
###xml 44 47 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
PKC isoforms are not upregulated in PKCtheta-/- mice.
###end title 36
###begin p 37
###xml 49 52 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Platelets lysates from wild-type (WT) or PKCtheta-/- (KO) mice were assessed for PKC isoform expression by SDS-PAGE and western blotting using specific antibodies for PKCalpha, -beta, -delta, -theta and -epsilon. Membranes were stripped and re-probed for alpha-tubulin as indicated to ensure equal loading of protein. Blots are representative of three independent experiments.
###end p 37
###begin title 38
PKCtheta has a small positive effect on platelet spreading on fibrinogen
###end title 38
###begin p 39
###xml 94 97 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 108 112 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Soriani1">[24]</xref>
###xml 379 382 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 394 401 386 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003277-t001">Table 1</xref>
###xml 753 759 745 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g002">Fig. 2</xref>
###xml 941 945 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-McCarty1">[26]</xref>
###xml 955 958 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1142 1145 1126 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
Others have reported that platelet spreading on fibrinogen was partially defective in PKCtheta-/- platelets [24]. We were able to confirm and extend this result, demonstrating that both adhesion of platelets and specifically the degree of filopodia generation, rather than lamellipodia, 45 minutes after static deposition on fibrinogen-coated coverslips, were reduced in PKCtheta-/- platelets (Table 1). We analysed the kinetics of the spreading process to determine any further qualitative differences in spreading. Platelets during/after spreading were scored for number of filopodia and categorized as having none, few (1 or 2), some (3, 4 or 5) or many (6 or more) filopodia. The relative frequency of each morphology was determined and is shown in Fig. 2. 45 minutes after deposition on the coverslip, most WT platelets had formed at least a few filopodia, although very few platelets formed lamellipodia, consistent with other reports [26]. PKCtheta-/- mice had a significantly different distribution of filopodial number, with a lower proportion forming 6 or more filopodia (p<0.001). As a consequence, a greater proportion of PKCtheta-/- platelets formed 0, 1 or 2 filopodia than WT platelets (p<0.001). Thus, PKCtheta has a small, positive regulatory role in filopodia generation on fibrinogen.
###end p 39
###begin title 40
PKCtheta positively regulates filopodia number when platelets spread on fibrinogen.
###end title 40
###begin p 41
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 224 227 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 243 244 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Platelets were deposited on fibrinogen-coated coverslips in a live-cell chamber for 45 min and visualized by DIC microscopy. Five fields of view were selected at random, and one such field is shown in (A) for WT and PKCtheta-/- platelets. In (B), filopodia number was counted for each visible platelet and the number of platelets with none, few (1-2), some (3-5) or many (6 or more) filopodia were expressed as a proportion of the total number of platelets in view. Shown are combined data from three independent experiments. Bar indicates 10 microm.
###end p 41
###begin title 42
PKCtheta does not regulate adhesion or spreading on CRP or collagen.
###end title 42
###begin p 43
###xml 369 370 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 458 459 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
Platelets were deposited on fibrinogen, CRP or collagen-coated coverslips in a live-cell chamber for 45 min and visualized by DIC microscopy. Five fields of view were selected at random and the number of adherent platelets was counted (adhesion) and spread surface area measured. Adhesion is total number of platelets adherent to the surface within a single 1000 microm2 field of view. Shown are combined data from three independent experiments (mean+/-SEM; * indicates p<0.05; ns = not significant).
###end p 43
###begin title 44
PKCtheta does not regulate adhesion or spreading on CRP or collagen
###end title 44
###begin p 45
###xml 238 239 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 243 244 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 378 385 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003277-t001">Table 1</xref>
Since PKCtheta had a role in platelet adhesion and spreading on fibrinogen, its role in adhesion and spreading on CRP and collagen was also assessed. CRP is a selective GPVI agonist, whereas collagen activates both GPVI and integrin alpha2beta1. In contrast to fibrinogen, no significant effect was seen on adhesion or total platelet surface area on either of these substrates (Table 1). Platelet interaction with collagen is therefore not affected by absence of PKCtheta.
###end p 45
###begin title 46
PKCtheta negatively regulates CRP-induced platelet activation
###end title 46
###begin p 47
###xml 207 210 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 214 215 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
We further investigated whether PKCtheta regulates platelet activation following GPVI stimulation. Activation of GPVI leads to secretion of alpha-granules and dense granules, and activation of integrin alphaIIbbeta3. The latter is known as inside-out signalling and is necessary for platelet aggregation.
###end p 47
###begin p 48
###xml 284 287 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 314 321 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g003">Fig. 3A</xref>
###xml 481 484 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 522 529 494 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g003">Fig. 3B</xref>
###xml 544 551 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g003">Fig. 3C</xref>
CRP-induced surface expression of P-selectin, a marker of alpha-granule release was enhanced in the absence of PKCtheta. In WT platelets, 1 microg/ml CRP induced a 3.1+/-0.5 -fold increase over basal in FITC-P-selectin fluorescence, which was increased to 10.2+/-3.0 -fold in PKCtheta-/- platelets (n = 8; p<0.05; Fig. 3A), suggesting that PKCtheta negatively regulates the release of these granules. Interestingly, however, no difference in ATP secretion was seen between PKCtheta-/- and WT platelets in response to CRP (Fig. 3B) or collagen (Fig. 3C).
###end p 48
###begin title 49
PKCtheta negatively regulates alpha-granule secretion.
###end title 49
###begin p 50
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 246 250 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A(i)</italic>
###xml 349 354 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A(ii)</italic>
###xml 376 380 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, C</italic>
###xml 436 437 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 452 453 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
A: Washed platelets from WT or KO mice were stimulated with CRP (1 or 5 microg/ml) in the presence of FITC-labelled anti-P-selectin antibody for 15 minutes, and surface labelling measured by flow cytometry. Representative histograms are shown in A(i) (1 microg/ml), and fold-increase in geometric mean compared to unstimulated platelets is shown in A(ii) (mean+/-SEM; n = 8). B, C: ATP secretion from dense granules in response to CRP (B) or collagen (C) was monitored in a luminometer using the luciferin-luciferase reaction. Data are presented as mean+/-SEM (n = 4).
###end p 50
###begin p 51
###xml 5 8 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 12 13 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 297 300 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 327 334 308 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g004">Fig. 4A</xref>
###xml 488 491 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 510 517 479 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g004">Fig. 4A</xref>
###xml 594 597 555 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 601 602 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 783 790 741 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g004">Fig. 4B</xref>
###xml 840 847 798 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g004">Fig. 4C</xref>
alphaIIbbeta3 activation was determined by flow cytometry using JON/A, an antibody that recognises the active conformation of this integrin. Importantly, JON/A binding was almost doubled in platelets activated by 1 microg/ml CRP, from 3.8+/-0.7 -fold over basal in WT to 7.5+/-1.8-fold in PKCtheta-/- platelets (n = 8; p<0.05; Fig. 4A). In contrast, a higher concentration of CRP (5 microg/ml) was not significantly affected (7.6+/-1.2 -fold in WT compared to 10.0+/-1.5 -fold in PKCtheta-/-; n = 8; p = 0.81; Fig. 4A). These data suggest that PKCtheta negatively regulates GPVI-dependent alphaIIbbeta3 activation, but that at high concentrations this inhibition can be overcome. Interestingly however, platelet aggregation was not affected at either of these concentrations of CRP (Fig. 4B), nor was collagen-induced aggregation affected (Fig. 4C).
###end p 51
###begin title 52
###xml 59 62 51 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 66 67 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
PKCtheta negatively regulates CRP-stimulated integrin alphaIIbbeta3 activation but not platelet aggregation.
###end title 52
###begin p 53
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 225 228 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(i)</italic>
###xml 327 331 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ii)</italic>
###xml 353 357 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, C</italic>
###xml 400 401 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 416 417 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 467 471 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B(i)</italic>
###xml 476 480 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C(i)</italic>
###xml 605 610 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B(ii)</italic>
###xml 615 620 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C(ii)</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
A: Washed platelets from WT or KO mice were stimulated with CRP (1 or 5 microg/ml) in the presence of PE-labelled JON/A for 15 minutes, and surface labelling measured by flow cytometry. Representative histograms are shown in (i) (1 microg/ml), and fold-increase in geometric mean compared to unstimulated platelets is shown in (ii) (mean+/-SEM; n = 8). B, C: Platelet aggregation in response to CRP (B) or collagen (C) was monitored by turbidometry. Traces, shown in B(i) and C(i), are representative of at least three separate experiments. Mean extent of aggregation at 5 min (+/-SEM; n = 3) is shown in B(ii) and C(ii), for CRP and collagen, respectively.
###end p 53
###begin title 54
###xml 49 57 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
PKCtheta negatively regulates thrombus formation in vitro
###end title 54
###begin p 55
###xml 14 17 10 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 65 54 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 69 70 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 397 399 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 456 464 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003277-g005">Figure 5</xref>
###xml 583 586 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
Since PKCtheta-/- aggregated normally, despite increased alphaIIbbeta3 activation and alpha-granule secretion, we investigated whether the role of PKCtheta might become more apparent during thrombus formation in the more physiological setting of flow conditions. Anticoagulated whole blood was passed over a collagen-coated coverslip through a parallel-plate flow chamber at a shear rate of 1000 s-1, and thrombi observed under phase contrast after 4 min. Figure 5 shows that platelets from WT mice formed substantial thrombi on the collagen surface, However, platelets from PKCtheta-/- formed significantly larger thrombi, suggesting that the negative role of PKCtheta is necessary to restrict thrombus size under flow conditions.
###end p 55
###begin title 56
###xml 72 80 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
PKCtheta negatively regulates thrombus formation on collagen under flow in vitro.
###end title 56
###begin p 57
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Whole blood was passed over a collagen-coated coverslip at 1000 s-1 for four minutes then observed by phase contrast microscopy (A). Surface coverage was measured and is shown in B as mean+/-SEM for three independent experiments. Bar indicates 10 microm.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 381 384 369 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 388 389 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
PKC activation is generally considered to positively regulate platelet signalling, since platelet activation is inhibited by broad-spectrum PKC inhibitors, and PKC activators can enhance platelet activation. However, here we show that the role of PKCtheta is more complicated than this, as it negatively regulates alpha-granule secretion and inside-out signalling to integrin alphaIIbbeta3, yet positively regulates outside-in integrin signalling. In the absence of PKCtheta, thrombus formation was markedly enhanced, suggesting that PKCtheta restricts thrombus size.
###end p 59
###begin p 60
###xml 54 57 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 171 175 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Soriani1">[24]</xref>
###xml 609 610 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 644 648 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-McCarty1">[26]</xref>
###xml 976 980 968 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Soriani1">[24]</xref>
###xml 1135 1136 1123 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1413 1417 1397 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-McCarty1">[26]</xref>
###xml 1419 1423 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Thornber1">[27]</xref>
###xml 1570 1573 1546 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1793 1796 1761 1764 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1800 1801 1765 1766 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
###xml 830 835 <span type="species:ncbi:9606">human</span>
First, we observed a significant reduction in PKCtheta-/- platelet adhesion and reduced spreading on fibrinogen compared to WT platelets, in agreement with Soriani et al. [24]. Interestingly, Soriani's study showed an approximately 50% reduction in spread platelet surface area whereas our study only showed a 13% reduction. This apparent quantitative (though not qualitative) discrepancy could result from technical differences between our experiments. We used DIC microscopy to image platelet spreading, and the surface area of platelets was measured by manually outlining each cell (approximately 25 microm2). Another study by McCarty et al [26] that used this approach saw a similar surface area. In both McCarty's study and ours, mouse platelets rarely formed large lamellipodia when spreading on fibrinogen, (in contrast to human platelets, which form full lamellipodia on fibrinogen) and filopodia were still apparent even after 45 minutes. In contrast, Soriani et al. [24] measured the surface area by confocal microscopy of rhodamine-phalloidin stained platelets, and reported a much lower surface area (approximately 8 microm2). Rather than measure the surface area directly, this method measures F-actin coverage, perhaps suggesting that PKCtheta regulates actin polymerization. WT platelets spread on fibrinogen and imaged using this method do not appear to exhibit the spiky morphology we and others [26], [27] observe using DIC microscopy. Our analysis suggests that PKCtheta positively regulates filopodia formation, since a smaller proportion of PKCtheta-/- platelets showed many (>5) filopodia compared to WT. Regardless of these quantitative differences, both of our studies qualitatively agree that PKCtheta is a positive regulator of outside-in signalling by integrin alphaIIbbeta3.
###end p 60
###begin p 61
###xml 61 64 53 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 68 69 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 213 216 198 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 220 221 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 243 246 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 437 440 407 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 444 445 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 610 613 569 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 617 618 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 659 663 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Soriani1">[24]</xref>
In contrast, PKCtheta negatively regulates GPVI-induced alphaIIbbeta3 activation. The selective GPVI agonist, CRP, induced a concentration-dependent increase in binding of JON/A, an activation state-specific alphaIIbbeta3 antibody. In PKCtheta-/- platelets this was markedly enhanced compared to WT at an intermediate concentration of CRP, though not at a higher concentration, suggesting that PKCtheta reduces expression of active alphaIIbbeta3 on the platelet surface, although inhibition can be overcome as agonist stimulation increases. It has been previously reported that PKCtheta does not regulate alphaIIbbeta3 activation in response to ADP or AYPGKF [24], both of which act through G protein-coupled receptors, suggesting that the regulatory role of PKCtheta may be specific to GPVI signalling.
###end p 61
###begin p 62
###xml 154 157 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 633 636 613 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 640 641 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 653 656 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 878 879 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 879 882 849 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 932 933 899 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1083 1087 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-HodivalaDilke1">[28]</xref>
###xml 1189 1192 1152 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
CRP-induced aggregation was not affected by the absence of PKCtheta, however. Similarly, collagen-induced aggregation was also the same in WT and PKCtheta-/- platelets. The lack of any effect on the rate or extent of aggregation was surprising, especially in response to 1 microg/ml CRP. At this concentration, the rate of aggregation was submaximal and yet the extent of integrin activation strongly enhanced. It might be expected, therefore, that the increased integrin activation would accelerate aggregation. However, since the extent of aggregation in response to 1 microg/ml CRP was almost maximal, further enhancement of alphaIIbbeta3 in PKCtheta-/- platelets can have little further effect. The apparent disparity between absolute levels of integrin activation and extent of aggregation highlights the large level in integrin reserve believed to exist in platelets. beta3+/- platelets, with only 50% of the WT levels of beta3 on their surface, have almost identical bleeding times and aggregation responses to PMA, ADP, thrombin and arachidonic acid compared to WT platelets [28]. In like manner, although WT platelets show approximately 50 % less integrin activation than PKCtheta-/- platelets at 1 microg/ml CRP, we should not expect this necessarily to relate to a difference in the extent of aggregation.
###end p 62
###begin p 63
###xml 312 315 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Strehl1">[2]</xref>
###xml 317 321 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Yoshioka1">[10]</xref>
###xml 323 327 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Tabuchi1">[11]</xref>
###xml 410 412 402 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 433 436 425 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Murugappan1">[5]</xref>
###xml 438 442 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Yoshioka1">[10]</xref>
###xml 444 448 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Tabuchi1">[11]</xref>
###xml 894 897 854 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Murugappan1">[5]</xref>
###xml 1059 1063 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Soltoff1">[29]</xref>
###xml 1064 1068 1016 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-McGovern1">[31]</xref>
###xml 1185 1188 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1194 1198 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Pula1">[13]</xref>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
PKCtheta also negatively regulates alpha-granule secretion, although no difference in dense granule secretion was observed. This suggests that the release of different platelet granules is regulated by distinct mechanisms. The PKC family in general is a critical positive regulator of platelet granule secretion [2], [10], [11], although this positive function is likely to be mediated through conventional (Ca2+-dependent) isoforms [5], [10], [11]. Thus, it appears that the different PKC isoforms have contrasting roles in platelet alpha-granule secretion: PKCalpha is critically required for alpha-granule secretion, and PKCtheta acts to counter this action. PKCalpha is also critically important for dense granule secretion, which is not countered by PKCtheta. It has been suggested that PKCdelta, closely related to PKCtheta, may negatively regulate GPVI-dependent dense granule secretion [5]. This interpretation was based on the use of rottlerin, a supposedly specific PKCdelta inhibitor (though several PKCdelta-independent targets have been reported [29]-[31]). However, we have previously reported that rottlerin enhances GPVI-dependent dense granule release even in PKCdelta-/- mice [13]. Thus, negative regulation of GPVI-dependent dense granule release does not appear to be mediated by either PKCdelta or PKCtheta.
###end p 63
###begin p 64
###xml 153 156 145 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 160 161 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 203 206 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 581 585 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003277-Nesbitt1">[32]</xref>
###xml 806 809 783 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 813 814 787 788 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1223 1226 1193 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PKCtheta negatively regulates thrombus formation under flow over a collagen-coated surface. Binding to collagen activates GPVI, leading to integrin alphaIIbbeta3 activation, which is enhanced in PKCtheta-/- platelets. The increased number of adhesive contacts between platelets may accelerate the growth of the thrombus. Thus, negative regulation of inside-out signalling by PKCtheta may be an important brake on thrombus growth at a site of injury. This effect is in contrast to the lack of effect seen in aggregation, highlighting the importance of physiological flow conditions [32]. In standard aggregometry, platelets exhibit a very large integrin reserve, whereas under flow, with higher shear force on any platelet-platelet interactions, integrin activation may be a limiting factor. Increased alphaIIbbeta3 activation would therefore enhance thrombus growth. This effect may be partially countered by the slightly reduced platelet adhesion to fibrinogen and reduced subsequent spreading, perhaps leading to fewer platelet-platelet contacts. Given the large effect on integrin activation compared to the smaller effect on spreading, however, the balance of these appears to favour increased thrombus size in PKCtheta-/- platelets.
###end p 64
###begin p 65
###xml 213 216 205 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 220 221 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 305 308 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
In summary, we have shown that PKCtheta negatively regulates GPVI-dependent inside-out signalling, in contrast to the positive role generally ascribed to the PKC family in general. Although enhanced integrin alphaIIbbeta3 activation does not lead to increased aggregation in an aggregometer tube, PKCtheta-/- platelets display enhanced thrombus formation on collagen under flow, suggesting that, under more physiological conditions, the regulatory role of PKCtheta may restrict thrombus size. This may impact on the clinical safety of PKCtheta inhibitors.
###end p 65
###begin p 66
###xml 133 137 <span type="species:ncbi:10090">mice</span>
We are grateful to Professor Dan Littman (Skirball Institute of Biomolecular Medicine, New York, USA) for generating the PKCtheta-/- mice used in this study, and to Professor Isabella Screpanti (University "La Sapienza", Rome, Italy) for supplying them. We thank Elizabeth Aitken for expert technical assistance supporting this work. We are grateful to Dr Mark Jepson and Alan Leard for their assistance within the School of Medical Sciences Wolfson Bioimaging Facility. AWP is a BBSRC Research Development Fellow.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
Isoform-specific functions of PKC: the platelet paradigm.
###end article-title 68
###begin article-title 69
Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets.
###end article-title 69
###begin article-title 70
###xml 94 99 <span type="species:ncbi:9606">human</span>
Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets.
###end article-title 70
###begin article-title 71
Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets. Cross-talk between tyrosine and serine/threonine kinases.
###end article-title 71
###begin article-title 72
###xml 85 90 <span type="species:ncbi:9606">human</span>
Differential role of PKC-delta isoform in agonist-induced dense granule secretion in human platelets.
###end article-title 72
###begin article-title 73
Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells.
###end article-title 73
###begin article-title 74
###xml 93 98 <span type="species:ncbi:9606">human</span>
Different translocation of three distinct PKC isoforms with tumor-promoting phorbol ester in human platelets.
###end article-title 74
###begin article-title 75
###xml 66 71 <span type="species:ncbi:9606">human</span>
Translocation of protein kinase C isozymes in thrombin-stimulated human platelets. Correlation with 1,2-diacylglycerol levels.
###end article-title 75
###begin article-title 76
###xml 66 71 <span type="species:ncbi:9606">human</span>
A new protein kinase C, nPKC eta, and nPKC theta are expressed in human platelets: involvement of nPKC eta and nPKC theta in signal transduction stimulated by PAF.
###end article-title 76
###begin article-title 77
Identification of protein kinase C-alpha as an essential, but not sufficient, cytosolic factor for Ca2+-induced alpha- and dense-core granule secretion in platelets.
###end article-title 77
###begin article-title 78
Direct demonstration of involvement of protein kinase C-alpha in the Ca2+-induced platelet aggregation.
###end article-title 78
###begin article-title 79
Regulation of outside-in signaling in platelets by integrin-associated protein kinase C-beta.
###end article-title 79
###begin article-title 80
PKC-delta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation.
###end article-title 80
###begin article-title 81
Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells.
###end article-title 81
###begin article-title 82
Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets.
###end article-title 82
###begin article-title 83
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells.
###end article-title 83
###begin article-title 84
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.
###end article-title 84
###begin article-title 85
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.
###end article-title 85
###begin article-title 86
###xml 20 24 <span type="species:ncbi:10090">mice</span>
PKC-theta-deficient mice are protected from Th1-dependent antigen-induced arthritis.
###end article-title 86
###begin article-title 87
###xml 122 126 <span type="species:ncbi:10090">mice</span>
Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.
###end article-title 87
###begin article-title 88
###xml 19 23 <span type="species:ncbi:10090">mice</span>
PKC-theta knockout mice are protected from fat-induced insulin resistance.
###end article-title 88
###begin article-title 89
Discovery of potent and selective PKC-theta inhibitors.
###end article-title 89
###begin article-title 90
Structure-based optimization of PKCtheta inhibitors.
###end article-title 90
###begin article-title 91
A role for PKC-theta in outside-in aIIbb3 signaling.
###end article-title 91
###begin article-title 92
Complementary roles of platelet glycoprotein VI and integrin a2b1 in collagen-induced thrombus formation in flowing whole blood ex vivo.
###end article-title 92
###begin article-title 93
Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow.
###end article-title 93
###begin article-title 94
Distinct but critical roles for integrin aIIbb3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin.
###end article-title 94
###begin article-title 95
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.
###end article-title 95
###begin article-title 96
Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation.
###end article-title 96
###begin article-title 97
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
###end article-title 97
###begin article-title 98
Kinase inhibitors: not just for kinases anymore.
###end article-title 98
###begin article-title 99
The impact of blood rheology on the molecular and cellular events underlying arterial thrombosis.
###end article-title 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 100
###begin p 101
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Supported by a British Heart Foundation programme grant to AWP (grant no. RG/05/015) and a grant from the Netherlands Foundation for Scientific research to JWMH (11-400-076). AWP is a BBSRC Research Development Fellow (BB/E024637/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 101

